Beta Bionics (BBNX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.53
- EPS estimate
- −$0.58
- EPS surprise
- +8.78%
- Revenue surprise
- +1.75%
- Revenue
- $32.0M
- Revenue estimate
- $31.5M
- Reported
- Jul 29, 2026
Beta Bionics reported Q2 2026 results on July 29, 2026. The company posted a loss of $0.53 per share, narrower than the estimated $0.58 loss, an 8.78% beat. Revenue was $32.0 million, above the $31.5 million consensus. Compared with Q2 2025, revenue rose about 38% from $23.2 million, while the loss per share widened from $0.39.
The record here is short, covering seven quarters from Q4 2024 to Q2 2026. Every quarter was a loss. The largest was $2.72 per share in Q4 2024. The one full year in the table, 2025, adds up to a loss of $1.95 per share on revenue of $100.2 million. Revenue has grown from $17.6 million in Q1 2025 to $32.0 million, with the high of $32.1 million in Q4 2025. The first half of 2026 shows a loss of $1.02 per share, against $1.32 a year earlier, on revenue about 46% higher. Beta Bionics beat the EPS estimate in five of the seven quarters, including each of the last five.
The only Q3 report in the table came on October 28, 2025. If that timing holds, the next report would come in late October or early November 2026.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | −$0.58 | −$0.53 | +8.78% | $32.0M | SEC |
| Q1 2026 | Apr 21, 2026 | −$0.50 | −$0.49 | +2.53% | $27.6M | SEC |
| Q4 2025 | Feb 17, 2026 | −$0.40 | −$0.30 | +25.60% | $32.1M | SEC |
| Q3 2025 | Oct 28, 2025 | −$0.42 | −$0.33 | +21.99% | $27.3M | SEC |
| Q2 2025 | Jul 29, 2025 | −$0.46 | −$0.39 | +15.01% | $23.2M | SEC |
| Q1 2025 | May 6, 2025 | −$0.48 | −$0.93 | −95.50% | $17.6M | SEC |
| Q4 2024 | Mar 25, 2025 | −$0.90 | −$2.72 | −202.22% | $20.4M | SEC |
Quarterly revenue
Frequently asked questions
When did Beta Bionics (BBNX) last report earnings?
Beta Bionics last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did BBNX beat earnings estimates?
Yes. Beta Bionics reported EPS of −$0.53 for Q2 2026 against a −$0.58 estimate — a 8.78% beat.
How much revenue did BBNX report last quarter?
Beta Bionics reported $32.0M in revenue for Q2 2026, against a consensus estimate of $31.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.